Aurinia Pharmaceuticals Inc. Stock price
Equities
AUPH
CA05156V1022
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.01 USD | +0.20% | -2.53% | -44.27% |
Mar. 20 | ILJIN SNT Delivers a Letter to Aurinia Pharmaceuticals | CI |
Mar. 07 | Aurinia Pharmaceuticals Insider Sold Shares Worth $711,094, According to a Recent SEC Filing | MT |
Financials (USD)
Sales 2024 * | 223M | Sales 2025 * | 288M | Capitalization | 723M |
---|---|---|---|---|---|
Net income 2024 * | -6M | Net income 2025 * | 58M | EV / Sales 2024 * | 1.7 x |
Net cash position 2024 * | 344M | Net cash position 2025 * | 390M | EV / Sales 2025 * | 1.16 x |
P/E ratio 2024 * |
-91.1
x | P/E ratio 2025 * |
12.7
x | Employees | 300 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.55% |
Latest transcript on Aurinia Pharmaceuticals Inc.
1 day | +0.20% | ||
1 week | -2.53% | ||
Current month | -12.41% | ||
1 month | -16.78% | ||
3 months | -46.07% | ||
6 months | -37.22% | ||
Current year | -44.27% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Martin
FOU | Founder | 52 | 93-06-15 |
Peter Greenleaf
CEO | Chief Executive Officer | 54 | 19-04-28 |
Robert Foster
FOU | Founder | 65 | 93-06-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Foster
FOU | Founder | 65 | 93-06-15 |
R. MacKay-Dunn
BRD | Director/Board Member | 73 | 19-06-25 |
Peter Greenleaf
CEO | Chief Executive Officer | 54 | 19-04-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.10% | 0 M€ | 0.00% | - | |
0.05% | 0 M€ | 0.00% | - | |
0.01% | 9 M€ | -.--% | - | |
0.01% | 735 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 5.01 | +0.20% | 1,374,533 |
24-03-27 | 5 | +1.42% | 1,438,779 |
24-03-26 | 4.93 | -1.20% | 948,678 |
24-03-25 | 4.99 | +0.40% | 969,097 |
24-03-22 | 4.97 | -0.80% | 1,792,314 |
Delayed Quote Nasdaq, March 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.27% | 723M | |
+2.73% | 108B | |
+9.59% | 104B | |
+6.58% | 23.66B | |
-12.59% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.29% | 16.19B | |
+4.68% | 13.72B | |
+34.25% | 12.22B |